These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16574954)

  • 1. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes.
    Ogata K; Kishikawa Y; Satoh C; Tamura H; Dan K; Hayashi A
    Blood; 2006 Aug; 108(3):1037-44. PubMed ID: 16574954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
    Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic flow cytometry for low-grade myelodysplastic syndromes.
    Ogata K
    Hematol Oncol; 2008 Dec; 26(4):193-8. PubMed ID: 18412289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
    Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
    Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
    Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
    Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.
    Xu F; Li X; Chang CK; Guo J; Wu LY; He Q; Zhang Z; Zhu Y; Gu SC; Shi WH; Song LX; Su JY; Zhou LY; Zhang X; Wu D
    PLoS One; 2014; 9(2):e88706. PubMed ID: 24558415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
    Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
    Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
    Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
    Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
    Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
    Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
    Rajab A; Porwit A
    Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.
    Ogata K; Della Porta MG; Malcovati L; Picone C; Yokose N; Matsuda A; Yamashita T; Tamura H; Tsukada J; Dan K
    Haematologica; 2009 Aug; 94(8):1066-74. PubMed ID: 19546439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.
    Della Porta MG; Picone C; Pascutto C; Malcovati L; Tamura H; Handa H; Czader M; Freeman S; Vyas P; Porwit A; Saft L; Westers TM; Alhan C; Cali C; van de Loosdrecht AA; Ogata K
    Haematologica; 2012 Aug; 97(8):1209-17. PubMed ID: 22315489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome].
    Li LJ; Fu R; Shao ZH; Wang HQ; Yue LZ; Ruan EB; Liu H; Wang J; Wang HL
    Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):963-6. PubMed ID: 21211213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones).
    Chen Z; Ok CY; Wang W; Goswami M; Tang G; Routbort M; Jorgensen JL; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2020 Jan; 98(1):36-42. PubMed ID: 31211490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
    Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
    Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.
    van de Loosdrecht AA; Westers TM; Westra AH; Dräger AM; van der Velden VH; Ossenkoppele GJ
    Blood; 2008 Feb; 111(3):1067-77. PubMed ID: 17971483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.